Meng Lou

602 total citations
21 papers, 457 citations indexed

About

Meng Lou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Meng Lou has authored 21 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Meng Lou's work include Metal-Catalyzed Oxygenation Mechanisms (4 papers), RNA modifications and cancer (4 papers) and DNA Repair Mechanisms (3 papers). Meng Lou is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (4 papers), RNA modifications and cancer (4 papers) and DNA Repair Mechanisms (3 papers). Meng Lou collaborates with scholars based in China, United States and Ecuador. Meng Lou's co-authors include Krishanu Saha, Jared Carlson-Stevermer, Amr A. Abdeen, Anna Huttenlocher, Jimin Shao, Davalyn R. Powell, Hongyan Qi, Jing Shen, Dongling Zou and Lijun Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Meng Lou

21 papers receiving 454 citations

Peers

Countries citing papers authored by Meng Lou

Since Specialization

Citations

This map shows the geographic impact of Meng Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Lou more than expected).

Fields of papers citing papers by Meng Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Lou. The network helps show where Meng Lou may publish in the future.

Co-authorship network of co-authors of Meng Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Lou. A scholar is included among the top collaborators of Meng Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Lou. Meng Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials 2024 ·Molecular Medicine ·Meng Lou, (unknown), Liying Zhang, Yongquan Lu, (unknown), Beige Zong	1
2	Downregulation of SOX2-OT Prevents Hepatocellular Carcinoma Progression Through miR-143-3p/MSI2 2021 ·Frontiers in Oncology ·(unknown), (unknown), Meng Lou, Xiaowei Yang, Liwen Sun	13
3	A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer 2021 ·Cell Death and Disease ·(unknown), Lijuan Guo, Hongyan Qi, Meng Lou, Rui Wang, (unknown), Kailun Xu, Lijun Zhu, Yongfeng Ding, Chen Li, (unknown), Jing Shen, Xueping Xiang, Jimin Shao	30
4	The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection. 2021 ·American Journal of Translational Research ·Liying Zhang, Liyuan Feng, Meng Lou, (unknown), (unknown), (unknown)	5
5	Aberrant methylation of GADD45A is associated with decreased radiosensitivity in cervical cancer through the PI3K/AKT signaling pathway 2020 ·Oncology Letters ·Meng Lou, Rong Li, Tingyuan Lang, Liying Zhang, Qi Zhou, Li Li	7
6	<p>miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway</p> 2019 ·OncoTargets and Therapy ·Hui Zhang, Tingyuan Lang, Dongling Zou, Lei Zhou, Meng Lou, Jingshu Liu, Yunzhe Li, (unknown), Yucong Li, (unknown), Xiaodong Zheng, (unknown), Qi Zhou, Li Li	24
7	Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo 2018 ·Scientific Reports ·Davalyn R. Powell, Meng Lou, (unknown), Anna Huttenlocher	49
8	Increased expression of Na+/H+ exchanger isoform 1 predicts tumor aggressiveness and unfavorable prognosis in epithelial ovarian cancer 2018 ·Oncology Letters ·Haixia Wang, (unknown), Dong Wang, Meng Lou, Dongling Zou, Rui Chen, Weiqi Nian, Qi Zhou	13
9	Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12/CXCR4 signalling axis 2018 ·Oncology Letters ·(unknown), Li Li, Qi Zhou, Haixia Wang, Dongling Zou, Dong Wang, Meng Lou, Weiqi Nian	27
10	Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy 2017 ·Journal of Biological Chemistry ·Meng Lou, Qian Liu, Guoping Ren, (unknown), Xueping Xiang, Yongfeng Ding, (unknown), Tingting Zhong, Xia Liu, Lijun Zhu, Hongyan Qi, Jing Shen, Haoran Li, Jimin Shao	20
11	Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing 2017 ·Nature Communications ·Jared Carlson-Stevermer, Amr A. Abdeen, (unknown), (unknown), (unknown), Meng Lou, Krishanu Saha	118
12	Silencing nc886, a Non-Coding RNA, Induces Apoptosis of Human Endometrial Cancer Cells-1A In Vitro 2017 ·Medical Science Monitor ·Zhuoying Hu, Hongyu Zhang, (unknown), Meng Lou, Yanqing Geng	19
13	ATR–CHK1–E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG 2016 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Chaoju Gong, Hong Liu, Rui Song, Tingting Zhong, Meng Lou, Tingyang Wang, Hongyan Qi, Jing Shen, Lijun Zhu, Jimin Shao	21
14	Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein 2016 ·Biochemical Pharmacology ·Xia Liu, Zhijian Xu, (unknown), Meng Wang, Xinhuan Chen, (unknown), (unknown), Meng Lou, Lijun Zhu, Yunqing Qiu, Zhi Chen, Chunhao Yang, Weiliang Zhu, Jimin Shao	42
15	High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells 2016 ·Stem Cell Reports ·Jared Carlson-Stevermer, (unknown), (unknown), (unknown), Meng Lou, (unknown), Ryan Prestil, Krishanu Saha	22
16	575. High Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells 2016 ·Molecular Therapy ·Jared Carlson-Stevermer, (unknown), (unknown), (unknown), Meng Lou, (unknown), Ryan Prestil, Krishanu Saha	1
17	Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis 2015 ·Tumor Biology ·Hongyan Qi, Meng Lou, (unknown), Xiyong Liu, (unknown), Jianzhen Shan, Zhi‐Qiang Ling, Jing Shen, Lijun Zhu, Yun Yen, Shu Zheng, Jimin Shao	12
18	Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis 2013 ·OncoTargets and Therapy ·(unknown), (unknown), Hongyan Qi, Meng Lou, Xia Liu, (unknown), (unknown), Weifeng Zhang, Jimin Shao, Jing Zhao	7
19	The Conserved Lys-95 Charged Residue Cluster Is Critical for the Homodimerization and Enzyme Activity of Human Ribonucleotide Reductase Small Subunit M2 2013 ·Journal of Biological Chemistry ·Xinhuan Chen, Zhijian Xu, (unknown), Hongchuan Liu, Xia Liu, Meng Lou, Lijun Zhu, Bingding Huang, Cai‐Guang Yang, Weiliang Zhu, Jimin Shao	6
20	Interferon Regulatory Factor 1 Transactivates Expression of Human DNA Polymerase η in Response to Carcinogen N-Methyl-N′-nitro-N-nitrosoguanidine 2012 ·Journal of Biological Chemistry ·Hongyan Qi, (unknown), Meng Lou, (unknown), Hong Liu, Jing Shen, Zhongjie Li, (unknown), Jianzhen Shan, Lijun Zhu, Y. Eugene Chin, Jimin Shao	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact